Cresco Labs (CRLBF) to Release Quarterly Earnings on Friday

Cresco Labs (OTCMKTS:CRLBF) is expected to post its quarterly earnings results before the market opens on Friday, March 21st. Analysts expect Cresco Labs to post earnings of ($0.02) per share for the quarter.

Cresco Labs Trading Down 6.0 %

Shares of OTCMKTS CRLBF opened at $0.70 on Friday. Cresco Labs has a 12-month low of $0.70 and a 12-month high of $2.60. The company has a market cap of $341.70 million, a price-to-earnings ratio of -3.50 and a beta of 1.79. The company has a current ratio of 1.97, a quick ratio of 1.39 and a debt-to-equity ratio of 1.80. The stock’s 50 day simple moving average is $0.89 and its 200 day simple moving average is $1.21.

Analyst Ratings Changes

Separately, Atb Cap Markets lowered shares of Cresco Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 9th. Four investment analysts have rated the stock with a hold rating, one has given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $2.50.

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.